Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study
Clinical Genitourinary Cancer(2022)
摘要
Response of VUC to pembrolizumab was not inferior to that of PUC in patients with advanced-stage bladder and upper urinary tract cancer.
更多查看译文
关键词
Advanced urothelial carcinoma,Histological variant,Immune checkpoint inhibitors,Prognosis,Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要